Lysimachia foenum-graecum
Lysimachia foenum-graecum · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Lysimachia foenum-graecum, commonly known as golden alexanders, is a medicinal herb that has garnered significant scientific interest due to its diverse pharmacological potential. Recent investigations have focused on the LFE and the butanol fraction of the aerial parts, which are specifically extracted using 70% EtOH to isolate bioactive compounds. Research into these preparations has revealed promising effects regarding the regulation of adipogenesis and the modulation of adiponectin levels. Furthermore, the plant demonstrates therapeutic relevance in addressing conditions such as ascariasis and providing physiological responses to cold stress. These findings highlight the complex chemical profile of the herb and its potential applications in metabolic and antiparasitic therapies.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Primulaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Taxonomy
Lysimachia foenum-graecum is a unique botanical specimen that belongs to the vast kingdom Plantae. Within this kingdom, the plant is classified under the class Equisetopsida and the order Ericales. It is further categorized into the family Primulaceae, which highlights its specific evolutionary lineage. As a member of the genus Lysimachia, it shares structural similarities with many of its close relatives. Understanding these hierarchical relationships provides essential insight into the biological identity of this species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Primulaceae |
| Genus | Lysimachia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Lysimachia foenum-graecum is a notable plant species with a specific geographic range found across the Asia-Temperate region. Its presence is particularly concentrated within various parts of China, where it thrives in diverse local environments. Specifically, the species is well-documented throughout China South-Central, highlighting its adaptability to those regional climates. Additionally, it maintains a significant distribution within China Southeast, extending its ecological footprint across the country. Together, these regions define the primary habitat where this plant can be naturally observed.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Lysimachia foenum-graecum is a versatile plant that exhibits a flexible growth habit. Depending on its specific environmental conditions, its stature typically ranges from a minimum of 0.2 m to a maximum of 0.6 m. In many established settings, the plant frequently maintains a more consistent height of at least 0.4 m.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Lysimachia foenum-graecum serves as a rich natural source for a variety of complex chemical compounds. Recent scientific investigations have focused on isolating specific triterpenoid saponins from the aerial parts of this plant. Among these identified substances is cyclaminorin, a compound that has been specifically highlighted for its biological potential. Researchers evaluated several of these isolated saponins, including cyclaminorin, against various human cancer cell lines to assess their cytotoxic properties. This study underscores the importance of exploring the chemical constituents of the plant for future medicinal applications.
Conditions
Lysimachia foenum-graecum contains triterpenoid saponins that exhibit cytotoxic activity against several human cancer cell lines. Specifically, components from the plant demonstrate the ability to treat the NCI-H460, MGC-803, and HepG2 cell lines. Research also indicates that these compounds can target the A549 lung cancer cell line. Furthermore, the plant's derivatives show effectiveness against the drug-resistant A549/CDDP cell line. These findings highlight the therapeutic potential of Lysimachia foenum-graecum across these diverse cancer models.
Preparations
Lysimachia foenum-graecum is utilized in various forms, including its use as a medicinal herb. It is prepared as LFE, an extract that has demonstrated significant anti-obesity effects in both in vitro and in vivo studies. Specific chemical components, such as triterpenoid saponins, are isolated from the butanol fraction of the aerial parts of the plant. Additionally, the herb is extracted with 70% EtOH to facilitate the isolation and purification of chemical constituents like new flavonoids. These diverse preparation methods allow researchers to study the plant's wide range of pharmacological properties.